35 results
8-K
EX-99.1
ACGN
Aceragen Inc
1 Dec 14
Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer
12:00am
creation, who led ViroPharma to become a widely admired company successfully delivering innovative treatments to patients with serious unmet medical needs … became a leading developer of innovative therapies for rare diseases, with the approval and commercialization of its lead product, Cinryze
8-K
EX-99.1
ACGN
Aceragen Inc
11 Jan 21
Idera Pharmaceuticals to Present at Upcoming Conferences
6:04am
Idera will deliver on its long history of innovative science and begin to turn that history into a business reality.”
The Company plans to share
425
BCRX
Biocryst Pharmaceuticals Inc.
7 Jun 18
Business combination disclosure
8:17am
Combination Highlights 5 James Geraghty Mark Goldberg, M.D. Maxine Gowen, Ph.D. Nancy Hutson, Ph.D. Kenneth B. Lee, Jr.
Creating a Leader in Innovative … year sales estimate $500 million Long-term expansion into I/O addressable and unaddressable tumors Innovative Portfolio of Late-Stage Programs 8
9
8-K
EX-99.1
ACGN
Aceragen Inc
17 Nov 20
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
4:20pm
, and commercialization of innovative therapies for rare diseases. He also held scientific and project management position at Intracel, Becton Dickson, and SmithKline
8-K
EX-99.1
ACGN
Aceragen Inc
14 Nov 22
Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:39pm
programs that we are developing to be innovative therapeutics capable of addressing the unmet medical needs of these individuals. To learn more about
DEFA14A
EX-99.1
1c7rebbsyxyp03jz1ht
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
sg00i
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
425
hqal3vj4wqgys1 9c
22 Jan 18
Business combination disclosure
12:00am
425
a0rv fjs5
22 Jan 18
Business combination disclosure
12:00am
425
rh74x0vrma7iboy1yj
21 Jun 18
Business combination disclosure
6:06am
8-K
EX-10.1
jf0wqxue eubqnuk
6 Mar 07
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial Results
12:00am